Back to Search
Start Over
Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohnʼs disease: A prospective pilot study
- Source :
- Inflammatory Bowel Diseases. 15:1460-1466
- Publication Year :
- 2009
- Publisher :
- Oxford University Press (OUP), 2009.
-
Abstract
- Background: The efficacy of infliximab for endoscopic recurrence after resection of Crohn's disease (CD) has not yet been reported. The aim of this prospective study was to investigate the impact of infliximab on early endoscopic lesions after resection for CD. Methods: Twenty-six patients maintaining clinical remission (CD activity index [CDAI] score
- Subjects :
- Male
Interleukin-1beta
Anti-Inflammatory Agents
Colonoscopy
Pilot Projects
Azathioprine
Gastroenterology
law.invention
Postoperative Complications
Crohn Disease
Randomized controlled trial
law
Secondary Prevention
Immunology and Allergy
Prospective Studies
Young adult
Mesalamine
Prospective cohort study
Crohn's disease
medicine.diagnostic_test
Anti-Inflammatory Agents, Non-Steroidal
Antibodies, Monoclonal
Middle Aged
Prognosis
medicine.anatomical_structure
Female
Immunosuppressive Agents
medicine.drug
Adult
medicine.medical_specialty
Adolescent
Enzyme-Linked Immunosorbent Assay
Ileum
Young Adult
Internal medicine
medicine
Humans
Aged
Interleukin-6
Tumor Necrosis Factor-alpha
business.industry
medicine.disease
Infliximab
Surgery
business
Follow-Up Studies
Subjects
Details
- ISSN :
- 10780998
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- Inflammatory Bowel Diseases
- Accession number :
- edsair.doi.dedup.....bf445698285f9dda6338c2c3acd34705
- Full Text :
- https://doi.org/10.1002/ibd.20915